Management of CSDH With or Without EMMA- a Randomized Control Trial

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2026

Conditions
Chronic Subdural Hematoma
Interventions
PROCEDURE

Embolization of the Middle Meningeal Artery

EMMA is performed inside of the blood vessels where tiny catheters are used to deliver polymer embolic agents to block small blood vessels supplying the brain coverings. A particulate polymer embolic agent (also called polyvinyl acrylate, PVA) or a liquid embolic agents (polymers of ethynyl vinyl alcohol, EVOH) can be used.

Trial Locations (1)

R3E 3P5

RECRUITING

University of Manitoba, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER